- Home » News and Events
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
×îÐÂÉ«ÇéӰƬ Completes $25 Million Expansion of its Clinical Supply Facility in Schorndorf, Germany
Jul 16, 2024
×îÐÂÉ«ÇéӰƬ today announced it has completed expansion of its clinical supply facility in Schorndorf, Germany.
Siren Biotechnology and ×îÐÂÉ«ÇéӰƬ Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer
May 8, 2024
×îÐÂÉ«ÇéӰƬ will provide process development and cGMP manufacturing of Siren Biotechnology’s AAV vector-based therapeutic candidates for use in clinical trials.
×îÐÂÉ«ÇéӰƬ Publishes Fifth Annual Corporate Responsibility Report
Mar 7, 2024
The 2023 Corporate Responsibility Report highlights progress across every pillar of ×îÐÂÉ«ÇéӰƬ’s corporate responsibility strategy – People, Environment, and Community.
Novo Holdings to Acquire ×îÐÂÉ«ÇéӰƬ
Feb 5, 2024
×îÐÂÉ«ÇéӰƬ and Novo Holdings have entered into a merger agreement under which Novo Holdings will acquire ×îÐÂÉ«ÇéӰƬ in an all-cash transaction that values ×îÐÂÉ«ÇéӰƬ at $16.5 billion on an enterprise value basis.
×îÐÂÉ«ÇéӰƬ Announces Addition of Potent Capsule Filling Capabilities for Inhaled Dry Powders at its Boston, MA USA Facility
Feb 2, 2024
These upgrades, including the addition of capacity for both development and commercial spray drying, now position ×îÐÂÉ«ÇéӰƬ as the CDMO with the largest GMP capacity for capsule spray-dried and carrier-based inhaled powders.
×îÐÂÉ«ÇéӰƬ Commits to Reducing Greenhouse Gas Emissions by 2030
Jan 25, 2024
The company also committed to engaging with its suppliers such that 70% of their emissions will have reduction goals aligned with science-based targets by the end of fiscal 2028.
×îÐÂÉ«ÇéӰƬ Appoints David McErlane as Biologics Segment Leader
Sep 18, 2023
Mr. McErlane will lead all of ×îÐÂÉ«ÇéӰƬ’s Biologics businesses and global service offerings – including development, drug substance manufacturing, drug product fill-and-finish, cell and gene therapy, and analytical services.
×îÐÂÉ«ÇéӰƬ Appoints Lisa Evoli Senior Vice President and Chief Human Resources Officer
Aug 1, 2023
She will be responsible for leading ×îÐÂÉ«ÇéӰƬ’s global human resources strategy, including talent acquisition, leadership development, diversity and inclusion, compensation and benefits, HR operations and technology, and performance management.
×îÐÂÉ«ÇéӰƬ Appoints Matti Masanovich Senior Vice President & Chief Financial Officer
Jun 20, 2023
Mr. Masanovich will have responsibility for all aspects of ×îÐÂÉ«ÇéӰƬ’s global financial operations, including financial planning and analysis, controllership, public reporting and investor relations, capital markets activities, bill payment and collection, tax, and treasury.
AAPS Summer Scientific Forum
Date: July 22-25, 2024
Inhaled Biologics: Preparing for a Future Beyond Small Molecules
Date: September 4-5, 2024